Annual FCF
-$251.13 M
+$53.32 M+17.51%
December 31, 2024
Summary
- As of March 10, 2025, RLAY annual free cash flow is -$251.13 million, with the most recent change of +$53.32 million (+17.51%) on December 31, 2024.
- During the last 3 years, RLAY annual FCF has fallen by -$173.25 million (-222.46%).
- RLAY annual FCF is now -448.04% below its all-time high of -$45.82 million, reached on December 31, 2018.
Performance
RLAY Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$57.87 M
+$17.44 M+23.16%
December 31, 2024
Summary
- As of March 10, 2025, RLAY quarterly free cash flow is -$57.87 million, with the most recent change of +$17.44 million (+23.16%) on December 31, 2024.
- Over the past year, RLAY quarterly FCF has stayed the same.
- RLAY quarterly FCF is now -225.35% below its all-time high of $46.16 million, reached on March 31, 2021.
Performance
RLAY Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$251.13 M
+$31.44 M+11.13%
December 31, 2024
Summary
- As of March 10, 2025, RLAY TTM free cash flow is -$251.13 million, with the most recent change of +$31.44 million (+11.13%) on December 31, 2024.
- Over the past year, RLAY TTM FCF has stayed the same.
- RLAY TTM FCF is now -1698.89% below its all-time high of -$13.96 million, reached on March 31, 2019.
Performance
RLAY TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
RLAY Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.5% | 0.0% | 0.0% |
| 3 y3 years | -222.5% | 0.0% | 0.0% |
| 5 y5 years | -238.7% | 0.0% | 0.0% |
RLAY Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -222.5% | +17.5% | -42.6% | +35.2% | -222.5% | +17.5% |
| 5 y | 5-year | -238.7% | +17.5% | -225.3% | +35.2% | -619.5% | +17.5% |
| alltime | all time | -448.0% | +17.5% | -225.3% | +35.2% | -1698.9% | +17.5% |
Relay Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$251.13 M(-17.5%) | -$57.87 M(-23.2%) | -$251.13 M(-11.1%) |
| Sep 2024 | - | -$75.31 M(+14.4%) | -$282.56 M(-0.2%) |
| Jun 2024 | - | -$65.84 M(+26.4%) | -$283.24 M(-1.5%) |
| Mar 2024 | - | -$52.10 M(-41.7%) | -$287.50 M(-5.6%) |
| Dec 2023 | -$304.44 M(+27.6%) | -$89.31 M(+17.5%) | -$304.44 M(+10.9%) |
| Sep 2023 | - | -$75.99 M(+8.4%) | -$274.53 M(+2.9%) |
| Jun 2023 | - | -$70.10 M(+1.5%) | -$266.78 M(+4.4%) |
| Mar 2023 | - | -$69.05 M(+16.2%) | -$255.63 M(+7.2%) |
| Dec 2022 | -$238.55 M(+206.3%) | -$59.40 M(-13.0%) | -$238.55 M(+8.6%) |
| Sep 2022 | - | -$68.24 M(+15.8%) | -$219.74 M(+6.4%) |
| Jun 2022 | - | -$58.95 M(+13.4%) | -$206.44 M(+17.3%) |
| Mar 2022 | - | -$51.97 M(+28.0%) | -$176.01 M(+126.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$77.88 M(-25.4%) | -$40.59 M(-26.1%) | -$77.88 M(+7.2%) |
| Sep 2021 | - | -$54.94 M(+92.6%) | -$72.63 M(+72.3%) |
| Jun 2021 | - | -$28.52 M(-161.8%) | -$42.16 M(+20.8%) |
| Mar 2021 | - | $46.16 M(-230.6%) | -$34.90 M(-66.6%) |
| Dec 2020 | -$104.42 M(+40.9%) | -$35.34 M(+44.4%) | -$104.42 M(+13.0%) |
| Sep 2020 | - | -$24.47 M(+15.1%) | -$92.44 M(+5.2%) |
| Jun 2020 | - | -$21.26 M(-9.0%) | -$87.86 M(+5.2%) |
| Mar 2020 | - | -$23.35 M(-0.0%) | -$83.53 M(+12.7%) |
| Dec 2019 | -$74.14 M(+61.8%) | -$23.36 M(+17.4%) | -$74.14 M(+46.0%) |
| Sep 2019 | - | -$19.89 M(+17.5%) | -$50.78 M(+64.4%) |
| Jun 2019 | - | -$16.93 M(+21.2%) | -$30.89 M(+121.2%) |
| Mar 2019 | - | -$13.96 M | -$13.96 M |
| Dec 2018 | -$45.82 M | - | - |
FAQ
- What is Relay Therapeutics annual free cash flow?
- What is the all time high annual FCF for Relay Therapeutics?
- What is Relay Therapeutics annual FCF year-on-year change?
- What is Relay Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Relay Therapeutics?
- What is Relay Therapeutics quarterly FCF year-on-year change?
- What is Relay Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Relay Therapeutics?
- What is Relay Therapeutics TTM FCF year-on-year change?
What is Relay Therapeutics annual free cash flow?
The current annual FCF of RLAY is -$251.13 M
What is the all time high annual FCF for Relay Therapeutics?
Relay Therapeutics all-time high annual free cash flow is -$45.82 M
What is Relay Therapeutics annual FCF year-on-year change?
Over the past year, RLAY annual free cash flow has changed by +$53.32 M (+17.51%)
What is Relay Therapeutics quarterly free cash flow?
The current quarterly FCF of RLAY is -$57.87 M
What is the all time high quarterly FCF for Relay Therapeutics?
Relay Therapeutics all-time high quarterly free cash flow is $46.16 M
What is Relay Therapeutics quarterly FCF year-on-year change?
Over the past year, RLAY quarterly free cash flow has changed by $0.00 (0.00%)
What is Relay Therapeutics TTM free cash flow?
The current TTM FCF of RLAY is -$251.13 M
What is the all time high TTM FCF for Relay Therapeutics?
Relay Therapeutics all-time high TTM free cash flow is -$13.96 M
What is Relay Therapeutics TTM FCF year-on-year change?
Over the past year, RLAY TTM free cash flow has changed by $0.00 (0.00%)